102 related articles for article (PubMed ID: 16215894)
41. The hepatix extracorporeal liver assist device in the treatment of fulminant hepatic failure.
Kelly JH; Sussman NL
ASAIO J; 1994; 40(1):83-5. PubMed ID: 7514459
[No Abstract] [Full Text] [Related]
42. Current status of artificial hepatic support systems.
Berk PD; Martin JF; Scharschmidt BF; Plotz PH
Prog Liver Dis; 1976; 5():398-417. PubMed ID: 775548
[No Abstract] [Full Text] [Related]
43. Correction of disturbed pathophysiology of hepatic failure by albumin dialysis.
Williams R
Hepatobiliary Pancreat Dis Int; 2008 Feb; 7(1):19-24. PubMed ID: 18234633
[No Abstract] [Full Text] [Related]
44. [Interest in therapeutic drug monitoring of the main antibiotics].
Davani S; Muret P; Royer B; Hoen B; Kantelip JP
Ann Biol Clin (Paris); 2002; 60(6):655-61. PubMed ID: 12446229
[TBL] [Abstract][Full Text] [Related]
45. Ceftriaxone effect on bilirubin-albumin binding.
Fink S; Karp W; Robertson A
Pediatrics; 1987 Dec; 80(6):873-5. PubMed ID: 3684399
[TBL] [Abstract][Full Text] [Related]
46. Acute alcoholic hepatitis.
Williams R
Z Gastroenterol; 2001 Jun; 39 Suppl 2():9-11. PubMed ID: 16215884
[No Abstract] [Full Text] [Related]
47. Introduction of new technologies for the treatment of diabetic complications: cryoreactive albumin removal apheresis.
Nosé Y; Ohta K; Suki WN; Takaba J; Miyamoto H
Artif Organs; 2011 Jan; 35(1):4-8. PubMed ID: 21226744
[No Abstract] [Full Text] [Related]
48. Tissue concentrations of third-generation cephalosporins (ceftazidime and ceftriaxone) in lower extremity tissues using a tourniquet.
Papaioannou N; Kalivas L; Kalavritinos J; Tsourvakas S
Arch Orthop Trauma Surg; 1994; 113(3):167-9. PubMed ID: 8054241
[TBL] [Abstract][Full Text] [Related]
49. Safety and pharmacokinetics of ceftazidime in patients with chronic hepatic dysfunction.
Pasko MT; Beam TR; Spooner JA; Camara DS
J Antimicrob Chemother; 1985 Mar; 15(3):365-74. PubMed ID: 3888944
[TBL] [Abstract][Full Text] [Related]
50. [Heparin and more].
Triolo G; Mariano F
G Ital Nefrol; 2008; 25(1):105. PubMed ID: 18264927
[No Abstract] [Full Text] [Related]
51. Therapeutic Apheresis and Dialysis: 20(th) Year of Publication.
Akizawa T
Ther Apher Dial; 2016 Feb; 20(1):5. PubMed ID: 26879489
[No Abstract] [Full Text] [Related]
52. An extracorporeal hollow fiber reactor for selective removal of antibodies or antigens.
Larue C; Gueraud V; Rivat C
Int J Artif Organs; 1985 Jul; 8 Suppl 2():23-6. PubMed ID: 4055107
[No Abstract] [Full Text] [Related]
53. Pharmacologic considerations with antimicrobials used in oncology.
Postelnick M; Halbur SR
Cancer Treat Res; 1998; 96():247-82. PubMed ID: 9711403
[No Abstract] [Full Text] [Related]
54. Albumin: biochemical properties and therapeutic potential.
Quinlan GJ; Martin GS; Evans TW
Hepatology; 2005 Jun; 41(6):1211-9. PubMed ID: 15915465
[No Abstract] [Full Text] [Related]
55. Author's Reply: Why Did the Patient Not Show Any Neurological Symptoms on the Day of the Higher Serum Concentration of Ceftriaxone?
Suzuki S; Naito S; Uchida S
Intern Med; 2019 Dec; 58(24):3617. PubMed ID: 31366808
[No Abstract] [Full Text] [Related]
56. Don't expect immediate miracles with metabolic assist devices.
Nosé Y
Artif Organs; 1978 Nov; 2(4):329. PubMed ID: 743000
[No Abstract] [Full Text] [Related]
57. Section V. Chronic intermittent haemodialysis and prevention of clotting in the extracorporal system.
European Best Practice Guidelines Expert Group on Hemodialysis, European Renal Association
Nephrol Dial Transplant; 2002; 17 Suppl 7():63-71. PubMed ID: 12386229
[No Abstract] [Full Text] [Related]
58. Extracorporeal support of liver function (II part).
Santoro A; Mancini E; Buttiglieri S; Krause A; Yakubovich M; Tetta C
Int J Artif Organs; 2004 Mar; 27(3):176-85. PubMed ID: 15112883
[No Abstract] [Full Text] [Related]
59. Why Did the Patient Not Show Any Neurological Symptoms on the Day of the Higher Serum Concentration of Ceftriaxone?
Fukuchi T; Sugawara H
Intern Med; 2019 Dec; 58(24):3615. PubMed ID: 31366806
[No Abstract] [Full Text] [Related]
60. Synthesis of plasma albumin and tissue proteins in regenerating liver.
BRAUN GA; MARSH JB; DRABKIN DL
Metabolism; 1962 Sep; 11():957-66. PubMed ID: 13872587
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
